Skip to main content

Advertisement

Table 1 Clinical Characteristics for Total Study Group

From: Clotting state after cardioversion of atrial fibrillation: a haemostasis index could detect the relationship with the arrhythmia duration

  Group A (n = 24) Group B (n = 18) Control Group (n = 19)
Age (years) 56 ± 11 61 ± 13 59 ± 12
Male gender 14(58%) 10(56%) 10(57%)
Smokers 15(62.5%) 11(62%) 11(62.5%)
Systolic Blood Pressure (mmHg) 145 ± 20 143 ± 22 139 ± 25
Diastolic Blood Pressure (mmHg) 80 ± 10 82 ± 11 80 ± 11
Known hypertension (160/90 mmHg) 8 (33.4%) 6 (34%) 7(35%)
Lone AF 11(45.8%) 8 (44.2%) -
Coronary artery Disease 5(20.8%) 4(22%) 5(22.8%)
Diabetes mellitus 6(25%) 4(22%) 4(22.3%)
Hct(%) 45.8 ± 3.9 44.9 ± 4.2 45 ± 3.6
Hb(g/dl) 15.3 ± 1.34 14.8 ± 2.9 15.2 ± 3.1
Fbg (mg/dl) 229.9 ± 27.0 237 ± 37.6 227 ± 26
P value: non significant (NS)
Echocardiographic data for Both Groups pre cardioversion
   Group A Group B
Left atrial diameter(cm)   4.2 ± 0.6 4.0 ± 0.8
Left ventricular diastolic dimension (cm)   5.2 ± 1.0 5.0 ± 0.9
Left ventricular systolic dimension (cm)   4.1 ± 0.5 4.0 ± 0.8
  1. P value: non significant (NS)